Compare Abeona Therapeutics Inc (ABEO) vs Cincinnati Financial Corporation (CINF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Cincinnati Financial Corporation — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Cincinnati Financial Corporation trades at $181.62 (market cap $29.25B). The key difference: Cincinnati Financial Corporation is far larger — about 78.4× Abeona Therapeutics Inc's market cap, and Cincinnati Financial Corporation pays a 1.99% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | CINF | |
|---|---|---|
Market Cap | $373.32M | $29.25B |
Sector | Health | Financials |
52-Week High | $7.23 | $192.03 |
52-Week Low | $4.17 | $145.80 |
Enterprise Value | $228.22M | $28.92B |
Dividend Yield | — | 1.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
Cincinnati Financial (CINF) trades at $189.06, down 1.55% on the day, but remains near its 52-week high. The stock shows strong fundamental performance with consistent earnings beats, a low P/E of 10.84, and robust profitability metrics including an 18.73% ROE. Recent technical indicators are mixed, with moving averages bullish but oscillators signaling overbought conditions. The company maintains a solid dividend track record, recently declaring a $0.94 dividend payable in July 2026.
CINF presents a compelling investment case supported by strong earnings growth, attractive valuation, and positive analyst sentiment, though near-term technical overbought signals and exposure to catastrophe losses pose risks. The consensus price target of $183.25 suggests limited upside from current levels, but long-term fundamentals remain sound.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Cincinnati Financial Corporation
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →
